


Healthcare News Roundup: Endocrinology
HSMN NewsFeed - 21 Nov 2006
BYETTA(R) (exenatide) Approved for Treatment of Type 2 Diabetes by European Commission
BYETTA(R) (exenatide) Approved for Treatment of Type 2 Diabetes by European Commission
HSMN NewsFeed - 2 Nov 2006
Bentley Pharmaceuticals Expands Phase II Clinical Trials of Intranasal Insulin Spray to the U.S.
Bentley Pharmaceuticals Expands Phase II Clinical Trials of Intranasal Insulin Spray to the U.S.
